University of Bristol spin-out raises more than £8m for new therapy targeting age-related sight loss
University of Bristol biotech spin-out company Cirrus Therapeutics has today (Thursday 2 October) announced the close of an £8 million seed financing to advance its pipeline of gene and cell therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback